Skip to main content
MAZE logo
MAZE
(NASDAQ)
Maze Therapeutics, Inc.
$27.69-- (--)
Loading... - Market loading

Maze Therapeutics (MAZE) Stock Price & Financial Analysis

Maze Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$27.50 - $28.61
52-Week High$53.65
52-Week Low$12.81
Open$28.20
Volume349.80K
Average Volume (3M)737.99K
Market Cap1.49B
Shares Outstanding53.90M
Price to Sales (P/S)74.62
Price to Book (P/B)4.37
EV/EBITDA-11.08
Revenue (TTM)20.00M
Net Income (TTM)-122.54M
Free Cash Flow (TTM)-122.13M
EPS (TTM)$-2.63
Profit Margin-612.71%
Operating Margin-670.26%
Return on Equity (ROE)-35.86%
Debt to Equity0.18
50-Day MA$26.99
200-Day MA$34.58
52-Week Change56.97%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Maze Therapeutics

What is the current stock price for MAZE?

As of the latest trading session, MAZE stock trades at $27.69. The 52-week range is $12.81–$53.65, with a day range of $27.50–$28.61.

What is the P/E ratio for MAZE?

The P/E ratio (Price-to-Earnings) for MAZE is shown in the Key Statistics section. This valuation metric helps compare Maze Therapeutics, Inc. to industry peers.

Does MAZE pay dividends?

Maze Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MAZE?

Based on 8 analysts, the consensus for MAZE is Buy.

What is the market cap of MAZE?

Maze Therapeutics's market capitalization is $1.49B, classifying it as a small-cap company. Maze Therapeutics operates in the Healthcare sector within the Biotechnology industry.